Companion Fund

www.digitalisventures.com/animal-health

VCMatch tracks Companion Fund as an investor focused on Biotech, Healthtech, and Medtech companies, Pre-Seed and Seed rounds, Global, United States, and New York City markets, and $300m to $800m check sizes. Upload your deck to compare your startup against the full private matching profile.

Check Size

$300m to $800m

Stages

Pre-Seed, Seed, Series A, Series B, Series C, Growth

Focus Areas

Biotech, Healthtech, Medtech

Geography

Global, United States, and New York City

Investment Thesis

Digitalis Ventures concentrates on investing in solutions to unmet needs in health by combining deep technical, financial, and domain expertise to creatively finance, build, and scale enduring enterprises. They emphasize rigorous problem-definition — believing that “accurately identifying and articulating the most critical unmet needs in health is the first and most fundamental step” — and support founders across stages with operational experience, long-term networks, and active knowledge creation (publishing, research, and industry engagement).

Is Companion Fund right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Companion Fund is most relevant for founders raising Pre-Seed, Seed, and Series A rounds in Biotech, Healthtech, Medtech, and Digital Health, especially across Global, United States, and New York City, with public check-size signals around $300m to $800m.

Focus statement

Digitalis invests in early-stage biotechnology for human health and in technology-enabled solutions that improve access to care and reduce costs, and—via its Companion Funds and a strategic partnership with Mars Petcare—invests in companies applying breakthrough science, technology, and design to improve animal health.

Value Add

Strategic corporate partnership with Mars Petcare that provides operational scale and market access: “In partnership with Mars Petcare... we provide operational experience and growth capital to founders across stages,” and access to “More than 70,000 Associates... caring for more than 25 million pets each year across 2,500+ clinics and labs.”
Integrated Digitalis ecosystem: part of the Digitalis Group which includes Digitalis Research (applied research) and Digitalis Commons (a non-profit building public-interest technologies), enabling research & mission-driven commercialization support.
Multidisciplinary, technical investor team and expansive network: they highlight “deep technical, financial, and domain expertise” and relationships with entrepreneurs, research institutions, and co-investors to forge long-term, operationally useful partnerships.
Active knowledge creation and public thought leadership: they “write and publish on life sciences, health technologies & services, and animal health,” using publishing to refine theses and influence markets.
Dual focus on human and animal health with One Health orientation: they explicitly connect animal and human health (e.g., Notes on Animal Health, One Health) to source opportunities and translate insights across species.
Emphasis on supporting companies through multiple rounds and operational scaling (not just capital): they state they “provide venture capital to early-stage companies... with the goal of supporting our portfolio companies throughout their development.”